TY  - GEN
AU  - Penland,Shannon K
AU  - Goldberg,Richard M
TI  - Combining anti-VEGF approaches with oxaliplatin in advanced colorectal cancer
SN  - 1533-0028
PY  - 2005///0118
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Bevacizumab
KW  - Clinical Trials, Phase III as Topic
KW  - Colorectal Neoplasms
KW  - drug therapy
KW  - Disease-Free Survival
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Neoplasm Invasiveness
KW  - pathology
KW  - Neoplasm Staging
KW  - Neovascularization, Pathologic
KW  - prevention & control
KW  - Organoplatinum Compounds
KW  - Phthalazines
KW  - Pyridines
KW  - Risk Assessment
KW  - Survival Analysis
KW  - Treatment Outcome
KW  - Vascular Endothelial Growth Factor A
N1  - Publication Type: Comparative Study; Journal Article; Review
UR  - https://doi.org/10.3816/ccc.2004.s.012
ER  -